JW Pharmaceutical's R&D spending South Korea 2014-2018

This statistic shows the research and development (R&D) expenditure of JW Pharmaceutical from 2014 to 2018. In 2018, JW Pharmaceutical's R&D spending amounted to approximately 34.38 billion South Korean won.
Click here to figure out JW Pharmaceutical's R&D expenditure to sales ratio for the same period.

JW Pharmaceutical's research and development (R&D) expenditure from 2014 to 2018

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2019

Region

South Korea

Survey time period

2014 to 2018

Supplementary notes

JW Pharmaceutical is a pharmaceutical company that has led the infusion solution (also known as intravenous/IV injection) market in South Korea.

Note: 1,000 South Korean won equal 0.82 U.S. dollars and 0.74 euros (as of August 2019).

Figures have been rounded.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Italy"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.